Loading stock data…
The Joint Corp (JYNT)
$8.33-0.19 (-2.23%)
After Hours$8.33+0.00 (+0.00%)· Last close Jun 29
The Joint Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Joint Corp. in the Healthcare sector is trading at $8.33 with a market capitalization of $132M. Wall Street consensus targets $10.00 (3 analysts), implying a +20.0% move over the next 12 months. The stock is currently near its 52-week low of $7.50, remaining 6.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +20.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $14.82M↓ | $15.17M↑ | $13.38M↑ | $13.27M↑ | $13.08M |
| Gross Profit | $12.10M↓ | $12.35M↑ | $10.72M↑ | $10.50M↑ | $10.11M |
| Operating Income | $898,995↑ | $743,895↑ | $160,915↑ | -$1.13M↓ | -$676,561 |
| Net Income | $1.30M↑ | $991,097↑ | $855,009↑ | $93,363↓ | $967,796 |
Peer Comparison
JNJUNHPFE
Fundamentals
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor mana...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$131.86M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
20.94%
Volume
Today's trading volume
153,135
Recent News
Joint Q1 Earnings Call Highlights
The Joint (NASDAQ:JYNT) reported first-quarter 2026 results that management said reflect improving profitability as the company nears completion of its “Joint 2.0” transformation into a “pure-play franchisor.” President and CEO Sanjiv Razdan highlighted progress on refranchising, marketing initiativ
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
The Joint (JYNT) delivered earnings and revenue surprises of +166.67% and +5.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
The Joint Corp. Q1 2026 Earnings Call Summary
Moby summary of The Joint Corp.'s Q1 2026 earnings call
Loss-Making The Joint Corp. (NASDAQ:JYNT) Set To Breakeven
With the business potentially at an important milestone, we thought we'd take a closer look at The Joint Corp.'s...
The Joint Corp. Q4 2025 Earnings Call Summary
Moby summary of The Joint Corp.'s Q4 2025 earnings call